CANSF
Price
$0.04
Change
-$0.01 (-20.00%)
Updated
Dec 18 closing price
LNTH
Price
$91.15
Change
-$1.51 (-1.63%)
Updated
Dec 18 closing price
63 days until earnings call
Ad is loading...

CANSF vs LNTH

Header iconCANSF vs LNTH Comparison
Open Charts CANSF vs LNTHBanner chart's image
Willow Biosciences
Price$0.04
Change-$0.01 (-20.00%)
Volume$94.5K
CapitalizationN/A
Lantheus Holdings
Price$91.15
Change-$1.51 (-1.63%)
Volume$1.41M
CapitalizationN/A
CANSF vs LNTH Comparison Chart
Loading...
CANSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANSF vs. LNTH commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANSF is a Hold and LNTH is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CANSF: $0.04 vs. LNTH: $91.15)
Brand notoriety: CANSF and LNTH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CANSF: 183% vs. LNTH: 124%
Market capitalization -- CANSF: $8.74M vs. LNTH: $4.27B
CANSF [@Pharmaceuticals: Other] is valued at $8.74M. LNTH’s [@Pharmaceuticals: Other] market capitalization is $4.27B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANSF’s FA Score shows that 0 FA rating(s) are green whileLNTH’s FA Score has 2 green FA rating(s).

  • CANSF’s FA Score: 0 green, 5 red.
  • LNTH’s FA Score: 2 green, 3 red.
According to our system of comparison, LNTH is a better buy in the long-term than CANSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANSF’s TA Score shows that 3 TA indicator(s) are bullish while LNTH’s TA Score has 4 bullish TA indicator(s).

  • CANSF’s TA Score: 3 bullish, 5 bearish.
  • LNTH’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, LNTH is a better buy in the short-term than CANSF.

Price Growth

CANSF (@Pharmaceuticals: Other) experienced а -23.64% price change this week, while LNTH (@Pharmaceuticals: Other) price change was -0.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.75%. For the same industry, the average monthly price growth was +1.64%, and the average quarterly price growth was -9.20%.

Reported Earning Dates

LNTH is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.75% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LNTH($4.27B) has a higher market cap than CANSF($8.74M). LNTH YTD gains are higher at: 47.016 vs. CANSF (-39.914). LNTH has higher annual earnings (EBITDA): 491M vs. CANSF (-10.02M). LNTH has more cash in the bank: 714M vs. CANSF (3.68M). CANSF has less debt than LNTH: CANSF (1.66M) vs LNTH (617M). LNTH has higher revenues than CANSF: LNTH (1.3B) vs CANSF (1.59M).
CANSFLNTHCANSF / LNTH
Capitalization8.74M4.27B0%
EBITDA-10.02M491M-2%
Gain YTD-39.91447.016-85%
P/E RatioN/A12.93-
Revenue1.59M1.3B0%
Total Cash3.68M714M1%
Total Debt1.66M617M0%
FUNDAMENTALS RATINGS
CANSF vs LNTH: Fundamental Ratings
CANSF
LNTH
OUTLOOK RATING
1..100
8818
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10021
SMR RATING
1..100
9921
PRICE GROWTH RATING
1..100
9142
P/E GROWTH RATING
1..100
9297
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LNTH's Valuation (72) in the Medical Specialties industry is in the same range as CANSF (92) in the null industry. This means that LNTH’s stock grew similarly to CANSF’s over the last 12 months.

LNTH's Profit vs Risk Rating (21) in the Medical Specialties industry is significantly better than the same rating for CANSF (100) in the null industry. This means that LNTH’s stock grew significantly faster than CANSF’s over the last 12 months.

LNTH's SMR Rating (21) in the Medical Specialties industry is significantly better than the same rating for CANSF (99) in the null industry. This means that LNTH’s stock grew significantly faster than CANSF’s over the last 12 months.

LNTH's Price Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for CANSF (91) in the null industry. This means that LNTH’s stock grew somewhat faster than CANSF’s over the last 12 months.

CANSF's P/E Growth Rating (92) in the null industry is in the same range as LNTH (97) in the Medical Specialties industry. This means that CANSF’s stock grew similarly to LNTH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANSFLNTH
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 1 day ago
73%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
CANSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SZK12.550.33
+2.73%
ProShares UltraShort Consumer Staples
GMF116.81-2.21
-1.86%
SPDR® S&P Emerging Asia Pacific ETF
BKGI29.83-0.70
-2.29%
BNY Mellon Global Infras Inc ETF
MSFO18.79-0.51
-2.64%
YieldMax MSFT Option Income Strategy ETF
RDVI24.07-0.78
-3.14%
FT Vest Ris Div Ach Trg Inc ETF

CANSF and

Correlation & Price change

A.I.dvisor tells us that CANSF and LNTH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANSF and LNTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANSF
1D Price
Change %
CANSF100%
-16.00%
LNTH - CANSF
21%
Poorly correlated
-1.63%
VTRS - CANSF
21%
Poorly correlated
-2.62%
CANQF - CANSF
6%
Poorly correlated
N/A
CNPOF - CANSF
1%
Poorly correlated
-6.67%
CRLBF - CANSF
1%
Poorly correlated
-0.68%
More

LNTH and

Correlation & Price change

A.I.dvisor tells us that LNTH and ACET have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LNTH and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNTH
1D Price
Change %
LNTH100%
-1.63%
ACET - LNTH
32%
Poorly correlated
-6.28%
SNDL - LNTH
26%
Poorly correlated
-2.86%
TEVA - LNTH
25%
Poorly correlated
+1.53%
LFCR - LNTH
24%
Poorly correlated
-7.10%
ORGO - LNTH
24%
Poorly correlated
-9.24%
More